Filing Flows › Companies › Cardinal Health › Timeline
Cardinal Health stock timeline
A year of the price with every insider trade, planned sale, earnings report and material 8-K marked
252 sessions+38.5% to $271.72
Cardinal Health (CAH) stock rose 39% over the last 252 sessions, to $271.72. On the way it reported 4 quarters, its insiders filed 8 open-market trades and 7 Form 144 notices of planned sales, and the company filed 4 material 8-Ks. Each is marked on the price and listed with what the stock did next.
Each mark, and what followed
| Date | Kind | What | Next session | 5 sessions | 21 sessions |
|---|---|---|---|---|---|
| Nov 5, 2026 | Earnings | Earnings: beat the EPS estimate by 10.9% | +2.2% (+6.7% vs SPY) | — | — |
| Aug 19, 2026 | Form 144 | Form 144: Mary Scherer plans to sell $546K | −0.1% (−0.3% vs SPY) | +1.2% (+1.4% vs SPY) | −3.7% (−3.1% vs SPY) |
| Aug 19, 2026 | Insider sale | Scherer Mary C. sold $546K | −0.1% (−0.3% vs SPY) | +1.2% (+1.4% vs SPY) | −3.7% (−3.1% vs SPY) |
| Aug 19, 2026 | Insider sale | Hollar Jason M. sold $10.5M | −0.1% (−0.3% vs SPY) | +1.2% (+1.4% vs SPY) | −3.7% (−3.1% vs SPY) |
| Aug 18, 2026 | Form 144 | Form 144: Jason Hollar plans to sell $29.4M | −0.3% (+0.4% vs SPY) | −1.4% (−0.2% vs SPY) | −1.3% (+1.1% vs SPY) |
| Aug 18, 2026 | Form 144 | Form 144: Stephen Mason plans to sell $8.3M | −0.3% (+0.4% vs SPY) | −1.4% (−0.2% vs SPY) | −1.3% (+1.1% vs SPY) |
| Aug 18, 2026 | Form 144 | Form 144: Jessica Mayer plans to sell $7.0M | −0.3% (+0.4% vs SPY) | −1.4% (−0.2% vs SPY) | −1.3% (+1.1% vs SPY) |
| Aug 18, 2026 | Form 144 | Form 144: Deborah Weitzman plans to sell $1.7M | −0.3% (+0.4% vs SPY) | −1.4% (−0.2% vs SPY) | −1.3% (+1.1% vs SPY) |
| Aug 18, 2026 | Form 144 | Form 144: Michelle Greene plans to sell $2.7M | −0.3% (+0.4% vs SPY) | −1.4% (−0.2% vs SPY) | −1.3% (+1.1% vs SPY) |
| Aug 18, 2026 | Form 144 | Form 144: Aaron Alt plans to sell $9.9M | −0.3% (+0.4% vs SPY) | −1.4% (−0.2% vs SPY) | −1.3% (+1.1% vs SPY) |
| Aug 18, 2026 | Insider sale | Weitzman Deborah sold $1.7M | −0.3% (+0.4% vs SPY) | −1.4% (−0.2% vs SPY) | −1.3% (+1.1% vs SPY) |
| Aug 18, 2026 | Insider sale | Mayer Jessica L sold $7.0M | −0.3% (+0.4% vs SPY) | −1.4% (−0.2% vs SPY) | −1.3% (+1.1% vs SPY) |
| Aug 18, 2026 | Insider sale | Mason Stephen M sold $8.3M | −0.3% (+0.4% vs SPY) | −1.4% (−0.2% vs SPY) | −1.3% (+1.1% vs SPY) |
| Aug 18, 2026 | Insider sale | Hollar Jason M. sold $18.9M | −0.3% (+0.4% vs SPY) | −1.4% (−0.2% vs SPY) | −1.3% (+1.1% vs SPY) |
| Aug 18, 2026 | Insider sale | Greene Michelle D. sold $2.7M | −0.3% (+0.4% vs SPY) | −1.4% (−0.2% vs SPY) | −1.3% (+1.1% vs SPY) |
| Aug 18, 2026 | Insider sale | Alt Aaron E sold $9.9M | −0.3% (+0.4% vs SPY) | −1.4% (−0.2% vs SPY) | −1.3% (+1.1% vs SPY) |
| Aug 11, 2026 | 8-K | Material definitive agreement | +1.3% (+1.6% vs SPY) | −0.6% (−0.6% vs SPY) | +1.2% (+2.6% vs SPY) |
| Aug 11, 2026 | Earnings | Earnings: beat the EPS estimate by 7.4% | +1.3% (+1.6% vs SPY) | −0.6% (−0.6% vs SPY) | +1.2% (+2.6% vs SPY) |
| Aug 5, 2026 | 8-K | Directors and officers: departures, appointments, pay | +2.4% (+2.6% vs SPY) | +2.8% (+2.9% vs SPY) | +5.0% (+5.8% vs SPY) |
| Apr 30, 2026 | Earnings | Earnings: beat the EPS estimate by 13.7% | −5.0% (−6.0% vs SPY) | −5.7% (−8.8% vs SPY) | −3.0% (−9.1% vs SPY) |
| Mar 23, 2026 | 8-K | Directors and officers: departures, appointments, pay | −0.7% (−1.7% vs SPY) | −0.6% (+1.7% vs SPY) | −1.2% (−9.4% vs SPY) |
| Mar 5, 2026 | 8-K | Directors and officers: departures, appointments, pay | −3.3% (−2.7% vs SPY) | −3.5% (−2.2% vs SPY) | −4.0% (+0.2% vs SPY) |
| Feb 5, 2026 | Earnings | Earnings: beat the EPS estimate by 11.2% | +9.4% (+10.6% vs SPY) | +8.1% (+7.2% vs SPY) | +5.1% (+7.2% vs SPY) |
Insiders’ record here
In the year on the chart, Cardinal Health's insiders reported 0 open-market buys ($0) and 8 sales ($59.6M).
Across the whole universe (19,782 scored trades), insider buys beat the market 46% of the time and sales were followed by a lagging stock 61% of the time; buys of $1M or more 39%. Every pattern →
What this kind of 8-K usually did
| Item | 8-Ks | Next session, median | Up next session | 21 sessions, median | Typical size |
|---|---|---|---|---|---|
| 5.02 Directors and officers: departures, appointments, pay | 39,174 | −0.1% | 48% | +0.7% | ±1.4% |
| 1.01 Material definitive agreement | 23,525 | 0.0% | 51% | +1.0% | ±1.4% |
| 1.02 Termination of a material agreement | 2,368 | 0.0% | 51% | +1.1% | ±1.5% |
| 2.03 New debt or off-balance-sheet obligation | 13,268 | 0.0% | 50% | +1.2% | ±1.3% |
Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →
Report card: every quarter against the estimate → Cardinal Health: every quarter → Live insider trades →
Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.